Register for the 2024 Personnel Placement Service (PPS) to request an interview.

Details

Posted: 10-Oct-24

Location: Lawrenceville, New Jersey

Type: Fellowship

Categories:

Clinical Pharmacist

Pharmacy

Specialty Practice Areas:

Neurology

Required Education:

PharmD

POST-DOCTORAL PHARMACEUTICAL INDUSTRY FELLOWSHIP – Rutgers, The State University of New Jersey, Ernest Mario School of Pharmacy, has over 40 years of expertise in offering innovative Post-Doctoral Pharm.D. Fellowships that provide extensive training in the pharmaceutical and biopharmaceutical industry. This 2-year Fellowship position is a joint effort between the Rutgers Institute for Pharmaceutical Industry Fellowships (RPIF) and Bristol Myers Squibb. Program emphasis is in US Immunology and Neuroscience Field Medical & Medical Evidence Generation (MEG). This 2-year Fellowship provides a unique opportunity to gain expertise in multiple dimensions of the medical affairs function in the immunology and neuroscience division. During their first year, the fellow will join the US Field Medical Immunology & Neuroscience team and participate in key projects, critical to the success of new product/indication launches and currently approved products.  The fellow will gain an appreciation for core Field Medical competencies spanning field training, resource creation, operations, and thought leader (TL)/ investigator engagement. In their second year, the fellow will join the MEG team and contribute to the development and implementation of the Integrated Evidence Plan (IEP) and interact with the different modalities of evidence generation (investigator-sponsored studies, interventional and noninterventional company-sponsored trials, collaborative research, data mining and exploratory analysis among others). The fellow will function as an Associate Clinical Scientist (CS) focusing on the science and strategy of medical affairs-sponsored trials (MASTs), learning various aspects of clinical studies (Phase IIIb/IV) including study design, initiation, maintenance, and closure activities.

US FIELD MEDICAL

• Serve as an integral part of the I&N (Immunology and Neuroscience) Field Medical Strategy and Training team and key contributor for field medical planning, stakeholder communications, and launch/life-cycle management projects
• Gain product and therapeutic expertise in I&N as foundational knowledge to apply to various projects and activities
• Collaborate with home office and field matrix teams to assist in the development of training initiatives and medical resources
• Contribute on innovative tactics and/or platforms to elevate MSL development and productivity in the field
• Participate in MSL trainings, assessments, and interactions. Fellow will have the opportunity to accompany MSLs on field rides and virtual interactions to gain an understanding of diverse experiences with TLs and study investigators

MEDICAL EVIDENCE GENERATION (MEG)

• Support the development, tracking and maintenance of Integrated Evidence Plans (IEPs) that reflect asset strategy, market priorities and medical evidence generation support in partnership with the I&N Global Medical Disease Team and cross-functional teams including Global Drug Development (GDD), Translational Development, Health Economics and Outcomes Research (HEOR), and others
• Develop Areas of Interest (AOI) based on key open data questions (ODQ) identified in the IEP with market input in collaboration with the I&F Global Medical Disease Team
• Manage the scientific aspects of the ongoing I&N Investigator-sponsored Research (ISR) book of work and interface with all key stakeholders across the matrix
• Conduct regular book of work reviews in partnership with GDO (Global Development Operations) with key medical and development stakeholders, under their remit. Identify studies at risk for failing to meet timelines and negotiated mitigation plans with key internal stakeholders and investigators
• Assist in the reviews of concepts through RFP (Request For Proposals) process, as appropriate, including providing context for ongoing book of work, area of interest development, and upcoming data read-outs
• On MAST studies, the Fellow will work closely with the CTL (Clinical Trial Lead) and study team in making study-specific recommendations, providing clinical research expertise, presenting protocol specific topics, responding to health authority requests, and supporting the team at various therapeutic area conferences.
• Support the study team in comprehensive clinical data review and analysis via available data review tools such as patient profiles, data review reports and data listings.

University-based experiences complement the industry experiences and include a Professional Development Series; opportunities for collaborative research, publication, and teaching; and participating/leading Rutgers Fellowship committees. These Fellowships provide a broad professional development opportunity in both corporate and academic environments to promote the role of Pharm.D.’s in the pharmaceutical and biopharmaceutical industry and help fuel your career as a future leader. For more information and to apply, please visit our website: http://pharmafellows.rutgers.edu

Do not click the “Apply Now” button to the right. We do not accept applications or schedule interviews with the PPS system, so please do not request an interview through this website. You can only apply at http://pharmafellows.rutgers.edu

The RPIF Program application portal opens at 9 AM ET on October 11th.  Initial interviews will be conducted on a rolling basis virtually (video conference) starting October 21st. To apply, candidates MUST use the RPIF website (http://pharmafellows.rutgers.edu/how-to-apply/) to create a RPIF Candidate Account and upload the required application materials by the dates noted below. Remember that the application process is on a rolling basis, so earlier is better.  Please see our website for additional important recruitment information and dates. 

Initial offers will not be made until December 16th, the AIFA (Alliance of Industry Fellowship Associates) consensus date for first offers.  Once all interviews have been completed, RPIF or the company will notify interviewed candidates of their position-specific candidacy status. 

Candidate Checklist:

1. Create an RPIF Candidate Account starting now.
2. Upload RPIF Application Materials to RPIF Candidate Account starting October 11, 2024. 
1. Applications are considered on a rolling basis. The earlier you submit materials, the sooner your candidacy can be considered. Complete the brief RPIF portal short-answer questions and you should upload your Letter of Intent and Curriculum Vitae (CV) by October 18, 2024.
2. Begin securing letters of recommendation because all 3 must be received before you can be fully considered for an offer. All 3 letters of recommendation should be submitted by December 1, 2024.
3. RPIF Representatives may reach out to schedule an interview. Please ensure your contact information is up to date.

As a University, Rutgers recognizes that the diversity of its workforce should reflect the diversity of the State and the students we serve. We strive to cultivate a culture of inclusion at Rutgers – one in which individuals of various backgrounds and belief systems can come together in an environment of mutual respect, learning from each other, and becoming better-prepared to participate in an increasingly globalized marketplace of ideas.

Rutgers University follows a policy to provide equal employment opportunity to all its employees and applicants for employment regardless of their race, creed, color, national origin, age, ancestry, nationality, marital or domestic partnership or civil union status, sex, pregnancy, gender identity or expression, disability status, liability for military service, protected veteran status, affectional or sexual orientation, atypical cellular or blood trait, genetic information (including the refusal to submit to genetic testing), or any other category protected by law.

Other commitments can be found at the link below:

https://uhr.rutgers.edu/prospective-employees/the-ru-commitment

About Rutgers, the State University of New Jersey

The Ernest Mario School of Pharmacy at Rutgers, The State University of New Jersey, is dedicated to excellence in healthcare and biomedical education, innovative and visionary research and scholarship in the pharmaceutical sciences, exemplary clinical practice, and outreach and community services that address the needs of the citizens of New Jersey and society at large. The School has a historic and profound commitment to public service – to pharmacists, the pharmaceutical industry, the health care community, government agencies, and the citizens of New Jersey.

Connections working at Rutgers, the State University of New Jersey